Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER). Colombel JF, Ungaro RC, Sands BE, Siegel CA, et al. Clin Gastroenterol Hepatol 2023 Sep 22:S1542-3565(23)00746.

Read + Share

Amedeo Smart

Independent Medical Education

Colombel JF, Ungaro RC, Sands BE, Siegel CA, et al. Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER). Clin Gastroenterol Hepatol 2023 Sep 22:S1542-3565(23)00746.
PMID: 37743037